Annemarie Boleij

10PUBLICATIONS
50CO-AUTHORS
PharmacogenomicsMicrobial geneticsHaematological tumoursCancer geneticsGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 31, 2026
Commonly prescribed drugs as risk factors for Clostridioides difficile infections: a Swedish population-based case-control study.

Annelies Boven, Harry Vranken, Erika Vlieghe

|Mar 05, 2026
The gut microbiome as a biomarker and modifiable risk factor in Lynch Syndrome.

Verona Sarena Colaco, Annemarie Boleij

|Jul 09, 2025
Cemiplimab in Locally Advanced or Metastatic Secondary Angiosarcomas (CEMangio): A Phase II Clinical Trial and Biomarker Analyses.

Stefan G van Ravensteijn, Jacco J de Haan, Hans Gelderblom

|May 27, 2023
Bacterial Oncotraits Rather than Spatial Organization Are Associated with Dysplasia in Ulcerative Colitis.

Carlijn E Bruggeling, Maarten Te Groen, Daniel R Garza

|Jun 28, 2021
Optimized bacterial DNA isolation method for microbiome analysis of human tissues.

Carlijn E Bruggeling, Daniel R Garza, Soumia Achouiti

|May 15, 2021
G-protein coupled receptor 35 (GPR35) regulates the colonic epithelial cell response to enterotoxigenic Bacteroides fragilis.

Annemarie Boleij, Payam Fathi, William Dalton

Pageof 2

Frequent Collaborators

2 joint publications

Rahwa Taddese

2 joint publications

Carlijn E Bruggeling

2 joint publications

Franck Housseau

2 joint publications

Cynthia L Sears